Basic Study
Copyright ©The Author(s) 2025.
World J Stem Cells. Jun 26, 2025; 17(6): 104367
Published online Jun 26, 2025. doi: 10.4252/wjsc.v17.i6.104367
Figure 6
Figure 6 Nuclear factor erythroid-derived 2 or mitofusin-2 knockdown impair the therapeutic effect of adipose-derived mesenchymal stem cell transplantation. A and B: Body weight and blood glucose of control, obesity mice transplanted with phosphate buffered saline and obesity mice transplanted with short hairpin RNA (shRNA) against nuclear factor erythroid-derived 2 (shNrf2) and shRNA against mitofusin-2 (shMfn2) young adipose-derived mesenchymal stem cells (n = 6); C and D: Glucose tolerance test and insulin tolerance test of each group after 8 weeks of transplantation (n = 6); E and F: Hemoglobin A1c (HbA1C) and insulin enzyme linked immunosorbent assay detection of each group after 8 weeks of transplantation (n = 3). aP < 0.05; bP < 0.01.